Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierk Thomas

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2014
Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224Panagiotis Xynogalos, Claudia Seyler, Daniel Scherer, et al.
Drug Design, Development and Therapy|November 26, 2014
Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of actionNadine Vonderlin, Fathima Fischer, Edgar Zitron, et al.
Cardiovascular Research|March 1, 2013
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathyJin Li, Claudia Seyler, Felix Wiedmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 3, 2017
Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP<sub>2</sub> interferenceDaniel Scherer, Benedikt Schworm, Claudia Seyler, et al.
Drug Design, Development and Therapy|March 4, 2015
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of actionNadine Vonderlin, Fathima Fischer, Edgar Zitron, et al.
Drug Design, Development and Therapy|July 8, 2017
Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantationRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 7, 2013
Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channelsAnn-Kathrin Rahm, Felix Wiedmann, Jakob Gierten, et al.
European Heart Journal|July 26, 2011
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot studyKerstin Trappe, Dierk Thomas, Olympia Bikou, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 22, 2013
The influence of endoscopic vein harvesting on outcomes after coronary bypass grafting: a meta-analysis of 267,525 patientsPriya Sastry, Rasmus Rivinius, Rebecca Harvey, et al.
Heart Rhythm|November 8, 2024
Comparative evaluation of 2 pulsed field ablation systems for atrial fibrillation: insights from real-world clinical implementation and short-term outcomesMaura M Zylla, Christine Mages, Ann-Kathrin Rahm, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2014
Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224Panagiotis Xynogalos, Claudia Seyler, Daniel Scherer, et al.
Drug Design, Development and Therapy|November 26, 2014
Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of actionNadine Vonderlin, Fathima Fischer, Edgar Zitron, et al.
Cardiovascular Research|March 1, 2013
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathyJin Li, Claudia Seyler, Felix Wiedmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 3, 2017
Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP<sub>2</sub> interferenceDaniel Scherer, Benedikt Schworm, Claudia Seyler, et al.
Drug Design, Development and Therapy|March 4, 2015
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of actionNadine Vonderlin, Fathima Fischer, Edgar Zitron, et al.
Drug Design, Development and Therapy|July 8, 2017
Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantationRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 7, 2013
Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channelsAnn-Kathrin Rahm, Felix Wiedmann, Jakob Gierten, et al.
European Heart Journal|July 26, 2011
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot studyKerstin Trappe, Dierk Thomas, Olympia Bikou, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 22, 2013
The influence of endoscopic vein harvesting on outcomes after coronary bypass grafting: a meta-analysis of 267,525 patientsPriya Sastry, Rasmus Rivinius, Rebecca Harvey, et al.
Heart Rhythm|November 8, 2024
Comparative evaluation of 2 pulsed field ablation systems for atrial fibrillation: insights from real-world clinical implementation and short-term outcomesMaura M Zylla, Christine Mages, Ann-Kathrin Rahm, et al.
Pageof 22